ES2082474T3 - Derivados de tetrahidrobenzazepina que inhiben la lipoxigenasa. - Google Patents
Derivados de tetrahidrobenzazepina que inhiben la lipoxigenasa.Info
- Publication number
- ES2082474T3 ES2082474T3 ES92911321T ES92911321T ES2082474T3 ES 2082474 T3 ES2082474 T3 ES 2082474T3 ES 92911321 T ES92911321 T ES 92911321T ES 92911321 T ES92911321 T ES 92911321T ES 2082474 T3 ES2082474 T3 ES 2082474T3
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- pct
- lipoxigenase
- sec
- lipoxygenase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
COMPUESTOS DE LA FORMULA (I) EN DONDE N ES DE 1 A 5 Y R ES HIDROGENO, ALKILO C1 A C4, ARILALKILO QUE TIENE DE UNO A CUATRO ATOMOS DE CARBONO EN LA UNIDAD DE ALKILO O ARILALKILO SUSTITUIDO POR UNO O MAS SUSTITUYENTES SELECCIONADOS INDEPENDIENTEMENTE DEL GRUPO QUE CONSISTE EN HALOGENO, NITRO, CIANO, ALKILO C1 A C6, ALCOXI C1 A C6, ALKILO HALOSUSTITUIDO C1 A C6, ALKILO HIDROXISUSTITUIDO C1 A C6, ALCOXICARBONILO C2 A C7 Y AMINOCARBONILO Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS, QUE INHIBEN LA LIPOXIGENESA DE LA ENZIMA Y SON UTILES PARA EL TRATAMIENTO DE ESTADOS ALERGICOS, INFLAMATORIOS Y CARDIOVASCULARES EN LOS QUE HA INTERVENIDO LA ACCION DE LA LIPOXIGENASA. ESTOS COMPUESTOS FORMAN EL INGREDIENTE ACTIVO DE LAS COMPOSICIONES FARMACEUTICAS PARA EL TRATAMIENTO DE TALES ESTADOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3158832A JPH0717612B2 (ja) | 1991-06-28 | 1991-06-28 | 新規なテトラヒドロベンズアゼピン誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2082474T3 true ES2082474T3 (es) | 1996-03-16 |
Family
ID=15680372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92911321T Expired - Lifetime ES2082474T3 (es) | 1991-06-28 | 1992-05-27 | Derivados de tetrahidrobenzazepina que inhiben la lipoxigenasa. |
Country Status (13)
Country | Link |
---|---|
US (1) | US5478822A (es) |
EP (1) | EP0591255B1 (es) |
JP (1) | JPH0717612B2 (es) |
AT (1) | ATE132857T1 (es) |
CA (1) | CA2111460C (es) |
DE (1) | DE69207597T2 (es) |
DK (1) | DK0591255T3 (es) |
ES (1) | ES2082474T3 (es) |
FI (1) | FI935867A (es) |
GR (1) | GR3019196T3 (es) |
IE (1) | IE70234B1 (es) |
PT (1) | PT100628A (es) |
WO (1) | WO1993000335A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5665768A (en) * | 1993-07-20 | 1997-09-09 | Pfizer Inc. | Heteroaryl cycloalkenyl hydroxyureas |
EP0920417A4 (en) * | 1996-08-15 | 1999-12-29 | Smithkline Beecham Corp | IL-8 RECEPTOR ANTAGONISTS |
EP1056187A4 (en) | 1998-02-13 | 2005-11-02 | Yaskawa Denki Seisakusho Kk | LINEAR MOTOR |
WO2001087834A1 (fr) * | 2000-05-16 | 2001-11-22 | Takeda Chemical Industries, Ltd. | Antagoniste de l'hormone de concentration de la melanine |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO165341C (no) * | 1985-03-16 | 1991-01-30 | Wellcome Found | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksamsyrearylderivater. |
DE3882732T2 (de) * | 1987-02-10 | 1993-12-02 | Abbott Lab | Indol, Benzofuran, Benzothiophen enthaltende, Lipoxygenase hemmende Verbindungen. |
ES2053609T3 (es) * | 1987-04-24 | 1994-08-01 | Abbott Lab | Derivados de urea inhibidores de lipoxigenasa. |
US4981865A (en) * | 1989-05-26 | 1991-01-01 | Warner-Lambert Co. | N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents |
-
1991
- 1991-06-28 JP JP3158832A patent/JPH0717612B2/ja not_active Expired - Fee Related
-
1992
- 1992-05-27 CA CA002111460A patent/CA2111460C/en not_active Expired - Fee Related
- 1992-05-27 AT AT92911321T patent/ATE132857T1/de not_active IP Right Cessation
- 1992-05-27 US US08/167,959 patent/US5478822A/en not_active Expired - Fee Related
- 1992-05-27 ES ES92911321T patent/ES2082474T3/es not_active Expired - Lifetime
- 1992-05-27 WO PCT/US1992/004197 patent/WO1993000335A1/en active IP Right Grant
- 1992-05-27 DK DK92911321.5T patent/DK0591255T3/da active
- 1992-05-27 DE DE69207597T patent/DE69207597T2/de not_active Expired - Fee Related
- 1992-05-27 EP EP92911321A patent/EP0591255B1/en not_active Expired - Lifetime
- 1992-06-26 PT PT100628A patent/PT100628A/pt not_active Application Discontinuation
- 1992-07-01 IE IE922075A patent/IE70234B1/en not_active IP Right Cessation
-
1993
- 1993-12-27 FI FI935867A patent/FI935867A/fi unknown
-
1996
- 1996-03-05 GR GR960400599T patent/GR3019196T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FI935867A0 (fi) | 1993-12-27 |
DK0591255T3 (da) | 1996-02-12 |
EP0591255B1 (en) | 1996-01-10 |
CA2111460C (en) | 1996-11-19 |
FI935867A (fi) | 1993-12-27 |
DE69207597D1 (de) | 1996-02-22 |
JPH059181A (ja) | 1993-01-19 |
GR3019196T3 (en) | 1996-06-30 |
IE70234B1 (en) | 1996-11-13 |
CA2111460A1 (en) | 1993-01-07 |
IE922075A1 (en) | 1992-12-30 |
US5478822A (en) | 1995-12-26 |
ATE132857T1 (de) | 1996-01-15 |
DE69207597T2 (de) | 1996-05-23 |
WO1993000335A1 (en) | 1993-01-07 |
PT100628A (pt) | 1993-09-30 |
EP0591255A1 (en) | 1994-04-13 |
JPH0717612B2 (ja) | 1995-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU95108387A (ru) | Дикетопиперазин, способ его получения, фармацевтическая композиция, применение дикетопиперазина | |
DE69431974D1 (de) | Benzamid-Derivate und ihre Verwendung als Vasopressin-Antagonisten | |
EA200200708A1 (ru) | Производные бензазола и их применение в качестве модуляторов jnk | |
MX9400253A (es) | Derivados de piperazina, proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
ATE224372T1 (de) | Substituierte 6-alkylphenanthridine | |
AR003137A1 (es) | Una composicion farmaceutica para tratar la leucemia | |
HUT59124A (en) | Process for producing 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxane derivatives and pharmaceutical compositions comprising such derivatives as active ingredient | |
ES2082474T3 (es) | Derivados de tetrahidrobenzazepina que inhiben la lipoxigenasa. | |
ES2121218T3 (es) | Fenoxifenilciclopentenilhidroxiureas. | |
BG106152A (en) | 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives | |
DK0588850T3 (da) | N-hydroxyureaderivater, som inhiberer lipoxygenase | |
DK0651743T3 (da) | Indolinyl-N-hydroxyurinstof- og N-hydroxamsyrederivater som lipoxygenaseinhibitorer | |
DK0596917T3 (da) | Benzimidazolanthelmintika | |
ATE146167T1 (de) | Cyclopropyl-n-hydroxyharnstoff als lypoxygenaseinhibitoren | |
KR960034199A (ko) | 피라졸을 함유한 벤즈이미다졸 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 591255 Country of ref document: ES |